Search company, investor...

IASON

Founded Year

2009

About IASON

IASON is a manufacturer and supplier of radiopharmaceuticals used in oncologic diagnostics. The company provides IASON Efdege, a fluorodeoxyglucos marked with the 18F isotope; and IASOflu, a sodium fluoride containing the 18F isotope. Its clients include diagnostics centers equipped with PET, PET-CT, or PET-MR cameras.

Headquarters Location

Rakowiecka 36

Warsaw, 02-532,

Poland

+48 223270900

Missing: IASON's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: IASON's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

IASON Patents

IASON has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/16/2010

11/7/2017

Lung cancer, Transcription factors, Brain tumor, Oncology, Experimental cancer drugs

Grant

Application Date

7/16/2010

Grant Date

11/7/2017

Title

Related Topics

Lung cancer, Transcription factors, Brain tumor, Oncology, Experimental cancer drugs

Status

Grant

IASON Frequently Asked Questions (FAQ)

  • When was IASON founded?

    IASON was founded in 2009.

  • Where is IASON's headquarters?

    IASON's headquarters is located at Rakowiecka 36, Warsaw.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.